Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Revol

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Therapie|February 23, 2021
[Thirty years of nefopam abuse in France]Bruno Revol, Jessica Delorme, Émilie Jouanjus, et al.
British Journal of Clinical Pharmacology|February 1, 2019
Pharmacokinetic herb-drug interaction between ginger and crizotinibBruno Revol, Elodie Gautier-Veyret, Capucine Arrivé, et al.
Respirology (Carlton, Vic.)|January 31, 2020
Valproic acid and sleep apnoea: A disproportionality signal from the WHO pharmacovigilance databaseBruno Revol, Ingrid Jullian-Desayes, Kelly Guichard, et al.
The European Respiratory Journal|January 13, 2018
Baclofen and sleep apnoea syndrome: analysis of VigiBase, the WHO pharmacovigilance databaseBruno Revol, Ingrid Jullian-Desayes, Sébastien Bailly, et al.
Harm Reduction Journal|July 28, 2023
NPAideS: a drug-checking study among 3-methylmethcathinone (3-MMC) usersThéo Willeman, Nathan Grundig, Christine Pochon, et al.
The European Respiratory Journal|March 9, 2019
Pulmonary arterial hypertension associated with protein kinase inhibitors: a pharmacovigilance-pharmacodynamic studyLucie Cornet, Charles Khouri, Matthieu Roustit, et al.
Clinical Chemistry and Laboratory Medicine|April 5, 2024
Smartphone swabs as an emerging tool for toxicology testing: a proof-of-concept study in a nightclubThéo Willeman, Justine Grunwald, Marc Manceau, et al.
Therapie|November 12, 2024
DRAMES and DTA databases: Complementary tools to monitor drug-related deaths in FranceBruno Revol, Théo Willeman, Marc Manceau, et al.
Sleep|May 13, 2022
Deprescribing antihypertensive drugs after starting OSA primary therapy?Bruno Revol, Christel Castelli, Raoua Ben Messaoud, et al.
Therapie|June 30, 2023
[Increase of overdose and deaths related to methadone during COVID-19 epidemic in 2020]Elisabeth Frauger, Nathalie Fouilhé, Clémence Lacroix, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Therapie|February 23, 2021
[Thirty years of nefopam abuse in France]Bruno Revol, Jessica Delorme, Émilie Jouanjus, et al.
British Journal of Clinical Pharmacology|February 1, 2019
Pharmacokinetic herb-drug interaction between ginger and crizotinibBruno Revol, Elodie Gautier-Veyret, Capucine Arrivé, et al.
Respirology (Carlton, Vic.)|January 31, 2020
Valproic acid and sleep apnoea: A disproportionality signal from the WHO pharmacovigilance databaseBruno Revol, Ingrid Jullian-Desayes, Kelly Guichard, et al.
The European Respiratory Journal|January 13, 2018
Baclofen and sleep apnoea syndrome: analysis of VigiBase, the WHO pharmacovigilance databaseBruno Revol, Ingrid Jullian-Desayes, Sébastien Bailly, et al.
Harm Reduction Journal|July 28, 2023
NPAideS: a drug-checking study among 3-methylmethcathinone (3-MMC) usersThéo Willeman, Nathan Grundig, Christine Pochon, et al.
The European Respiratory Journal|March 9, 2019
Pulmonary arterial hypertension associated with protein kinase inhibitors: a pharmacovigilance-pharmacodynamic studyLucie Cornet, Charles Khouri, Matthieu Roustit, et al.
Clinical Chemistry and Laboratory Medicine|April 5, 2024
Smartphone swabs as an emerging tool for toxicology testing: a proof-of-concept study in a nightclubThéo Willeman, Justine Grunwald, Marc Manceau, et al.
Therapie|November 12, 2024
DRAMES and DTA databases: Complementary tools to monitor drug-related deaths in FranceBruno Revol, Théo Willeman, Marc Manceau, et al.
Sleep|May 13, 2022
Deprescribing antihypertensive drugs after starting OSA primary therapy?Bruno Revol, Christel Castelli, Raoua Ben Messaoud, et al.
Therapie|June 30, 2023
[Increase of overdose and deaths related to methadone during COVID-19 epidemic in 2020]Elisabeth Frauger, Nathalie Fouilhé, Clémence Lacroix, et al.
Pageof 6